Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$102.72 USD
-0.24 (-0.23%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $102.67 -0.05 (-0.05%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$102.72 USD
-0.24 (-0.23%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $102.67 -0.05 (-0.05%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth A Momentum B VGM
Zacks News
LabCorp Diagnostics Strong on Novant Health Deal Extension
by Zacks Equity Research
Laboratory Corporation of America Holdings (LH), also referred to as LabCorp, has decided to extend its Technical Services Agreement with Novant Health which was originated in 2012.
Medtronic (MDT) Launches Resolute Onyx DES Device in Japan
by Zacks Equity Research
Medtronic plc (MDT), a leading global player in medical technology, services and solutions, is set to make another encouraging move with respect to its highest revenue grossing Cardiovascular segment.
Thermo Fisher at a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of Thermo Fisher Scientific Inc. (TMO), headquartered in Waltham, MA, scaled a new 52-week high of $177.99 on Jul 7, eventually closing a shade lower at $177.49.
Investors Look for Gains as Abbott Labs Set to Acquire Alere
by Zacks Equity Research
On majority of Alere shareholders' recent approval in favor of the merger with Abbott (ABT), the deal is now expected to close by the end of third-quarter 2017.
Phibro Animal Health & Zydus Cadila Plan to Expand in India
by Zacks Equity Research
Phibro Animal Health Corporation (PAHC) recently announced plans to enter into a long-term agreement with global pharmaceutical company Zydus Cadila to expand in the rapidly growing poultry market in India.
Exactech Boosts Knee System Portfolio, Launches New App
by Zacks Equity Research
Exactech, Inc.(EXAC) took a step towards it's goal of providing an all-inclusive range of knee replacement systems with the launch of ExactechGPS TKA PLUS.
Here's Why You Should Add Abbott Laboratories Right Now
by Zacks Equity Research
Illinois-based global medical device company Abbott Laboratories (ABT) has been gaining investor confidence on consistent positive results
Abbott Freestyle Libre System Gets Health Canada License
by Zacks Equity Research
Abbott Laboratories (ABT) recently announced the receipt of Health Canada license for its FreeStyle Libre Flash Glucose Monitoring System.
5 Underfollowed Stocks That Are Projected To Explode
by Jeffrey Hymen
These stocks represent a few investments that could possibly turn out to be hidden gems.
2 Solid Medical Device Stocks to Scoop Up Right Away
by Zacks Equity Research
Let's focus on two medical device stocks which will make valuable additions to an investment portfolio in the wake of widespread volatility in the medical device market.
The Zacks Analyst Blog Highlights: United Technologies, Abbott, Delta Air, Equity Residential and Ross Stores
by Zacks Equity Research
The Zacks Analyst Blog Highlights: United Technologies, Abbott, Delta Air, Equity Residential and Ross Stores
Abbott Laboratories Up on EPD & Buyouts, Pediatric Weak
by Zacks Equity Research
On Jun 14, we issued an updated research report on Illinois-based Abbott Laboratories (ABT). It is a leading distributor of health care products and services across the globe.
Abbott Laboratories at 52-Week High on Product Line, Buyouts
by Zacks Equity Research
Share price of IL-based Abbott Laboratories (ABT) scaled a new 52-week high of $46.55 on Jun 2, eventually closing a bit lower at $46.50.
The Zacks Analyst Blog Highlights: Alphabet, Morgan Stanley, Abbott, Waste Management, General Mills and Raytheon
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alphabet, Morgan Stanley, Abbott, Waste Management, General Mills and Raytheon
Abbott Labs (ABT) Down 2.3% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Abbott Labs (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: General Dynamics, EOG Resources, Abbott, Northrop Grumman and Symantec
by Zacks Equity Research
The Zacks Analyst Blog Highlights: General Dynamics, EOG Resources, Abbott, Northrop Grumman and Symantec
Abbott Lab Well Poised on Strong EPD, St. Jude Integration
by Zacks Equity Research
On May 17, we issued an updated research report on Abbott Laboratories (ABT).
Company News for April 20, 2017
by Zacks Equity Research
Companies in the News are: LRCX,FB,RARE,ABT
Q1 Scorecard & Stock Research Reports for IBM, Abbott and others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including IBM (IBM), Abbott (ABT) and Dow Chemical (DOW).
Abbott (ABT) Tops Q1 Earnings on Strong EPD, Medical Device
by Zacks Equity Research
Abbott Laboratories (ABT) reported first-quarter 2017 adjusted earnings from continuing operations of 48 cents per share, up 17.1% year over year.
Abbott Laboratories (ABT) Tops Q1 Earnings & Sales Estimates
by Zacks Equity Research
Currently, Abbott Labs has a Zacks Rank #3 (Hold), but that could definitely change following the company's first quarter 2017 earnings report which was just released.
Company News for April 18, 2017
by Zacks Equity Research
Companies in the News are: MGI,LLY,ASH,ALR,ABT
Company News for April 17, 2017
by Zacks Equity Research
Companies in the News are: ABT,UAL,GS,PIR
Abbott Laboratories Agrees to Acquire Alere at Lower Price
by Zacks Equity Research
Abbott has agreed to pay $51 per common share to acquire Alere, a reduction from earlier deal of $56 per common share upon the completion of the transaction.
Will Abbott Lab (ABT) Surprise Estimates in Q1 Earnings?
by Zacks Equity Research
Abbott Laboratories (ABT) is scheduled to report first-quarter 2017 results before the opening bell on Apr 19.